Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001206774-11-001781
Filing Date
2011-08-05
Accepted
2011-08-05 16:45:48
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT geron_10q.htm 10-Q 609542
2 AMENDED AND RESTATED 2006 DIRECTORS? STOCK OPTION PLAN. exhibit10-2.htm EX-10.2 91804
3 OFFER LETTER AGREEMENT BETWEEN REGISTRANT AND MELANIE I. NALLICHERI exhibit10-3.htm EX-10.3 8845
4 CERTIFICATION OF INTERIM CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER exhibit31-1.htm EX-31.1 9609
5 CERTIFICATION OF INTERIM CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER exhibit32-1.htm EX-32.1 3662
  Complete submission text file 0001206774-11-001781.txt   2585659

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gern-20110630.xml EX-101.INS 396156
7 XBRL TAXONOMY EXTENSION SCHEMA gern-20110630.xsd EX-101.SCH 11377
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20110630_pre.xml EX-101.PRE 60092
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20110630_lab.xml EX-101.LAB 106625
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gern-20110630_cal.xml EX-101.CAL 23748
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gern-20110630_def.xml EX-101.DEF 44899
Mailing Address 200 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 111014755
SIC: 2834 Pharmaceutical Preparations